Optimal endoscopy screening and surveillance intervals for colorectal cancer
We would like to utilize PLCO trial data for the following aims. The outcome will be incidence and mortality of CRC.
1. We will generate a risk score incorporating patient factors and polyps factors.
2. We will develop a personalized strategy to determine an optimal screening and surveillance interval.
REFERENCES
1. Nishihara, R, Wu, K, Lochhead, P, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. New England Journal of Medicine 2013; 369: 1095-1105.
2. Lieberman, DA, Rex, DK, Winawer, SJ, Giardiello, FM, Johnson, DA, Levin, TR, Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on colorectal cancer. Gastroenterology 2012; 143: 844-857.
Dr. Donna Spiegelman
Dr. Yin Cao
Dr. Reiko Nishihara